CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 2 of 16

Arthritis & Rheumatology

Briefs 41–80 of 607 CurrentRheuma has covered from this journal, newest publication first

Latest from Arthritis & Rheumatology

All coverage, newest first

  1. Arthritis Rheumatol

    Risk of Cancer According to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study From the French Health Insurance Database

    Cohort studySpondyloarthritis & PsA

  2. Arthritis Rheumatol

    Single‐Cell Profiling of Lymphoid and Myeloid Compartments Reveals Coordinated Immune Dysregulation and Enhanced Monocyte‐Centric Intercellular Communication in Relapsing Polychondritis

    Mechanistic studyAutoinflammatory & rare

  3. Arthritis Rheumatol

    Type I Interferon Drives Dysfunction of a Distinct CD8 + HLA ‐ DRB1 + T Cell Subset in Systemic Lupus Erythematosus

    Mechanistic studyLupus & APS

  4. Arthritis Rheumatol

    Anifrolumab Versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus

    Cohort studyLupus & APS

  5. Arthritis Rheumatol

    Outcomes in Progressive Pulmonary Fibrosis in Systemic Autoimmune Rheumatic Diseases: Real‐World Data From the ILD ‐ PRO Registry

    Cohort studyAcross diseases

  6. Arthritis Rheumatol

    Age‐Associated B Cells Contribute to Inflammation Via Antibody‐Independent Mechanisms in Takayasu Arteritis

    Mechanistic studyVasculitis & PMR

  7. Arthritis Rheumatol

    Redefining the Landscape: Acquired Mutations Driving Systemic Autoinflammatory Diseases

    Cohort studyAutoinflammatory & rare

  8. Arthritis Rheumatol

    Anti–Carbamylated Fibrinogen Autoantibodies of IgG and IgA Isotypes Contribute to a Better Prognostic Stratification in Very Early Rheumatoid Arthritis: Data From the French National ESPOIR Cohort

    Cohort studyRA

  9. Arthritis Rheumatol

    Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety Up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA ‐2 Trial

    Randomized controlled trialSpondyloarthritis & PsA

  10. Arthritis Rheumatol

    A Multicenter Integrative Cohort Characterizing the Genetic, Clinical, and Transcriptomic Features of ACP5 Deficiency

    Cohort studyAutoinflammatory & rare

  11. Arthritis Rheumatol

    Evans Syndrome Predicts Progression to Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus in Children With Persistent Antiphospholipid Antibodies: A Prospective Cohort Study With Up to 29 Years of Follow‐Up

    Cohort studyPediatric

  12. Arthritis Rheumatol

    The Role of Anti‐Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti‐Phospholipid Antibody‐Associated Preterm Delivery

    Cohort studyLupus & APS

  13. Arthritis Rheumatol

    Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

    Research articlePediatric

  14. Arthritis Rheumatol

    Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease

    Cohort studySjögren's & overlap

  15. Arthritis Rheumatol

    Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

    Cohort studyRA

  16. Arthritis Rheumatol

    Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis

    Cross-sectional studySpondyloarthritis & PsA

  17. Arthritis Rheumatol

    Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

    Randomized controlled trialGout & crystals

  18. Arthritis Rheumatol

    Diagnostic Value and Treatment Responsiveness of Ultrasonography Features in Correlation With Clinical Findings in Early Peripheral Spondyloarthritis

    Secondary analysisSpondyloarthritis & PsA

  19. Arthritis Rheumatol

    Fibroblast Mitochondrial Ca 2+ Overload Drives Skin Fibrosis via Mitochondrial DNA Leakage and Cyclic GMP ‐ AMP Synthase–Stimulator of Interferon Genes Activation in Systemic Sclerosis

    Mechanistic studySystemic sclerosis

  20. Arthritis Rheumatol

    Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

    Mechanistic studyRA

  21. Arthritis Rheumatol

    The Role of IgM Anti‐acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis

    Mechanistic studyRA

  22. Arthritis Rheumatol

    From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

    Cohort study

  23. Arthritis Rheumatol

    Increased Plasma Microbial tDR ‐1 in At‐Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response

    Case-control studyRA

  24. Arthritis Rheumatol

    Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression

    Mechanistic studySjögren's & overlap

  25. Arthritis Rheumatol

    Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome

    Cohort studyMyositis

  26. Arthritis Rheumatol

    Multimodal Peripheral Blood Immunophenotyping and Single‐Cell Epigenetic Analysis of Knee Osteoarthritis Reveals Expansion and Epigenetic Dysregulation of Treg Cell and Nonclassical Monocyte Populations

    Mechanistic studyOsteoarthritis

  27. Arthritis Rheumatol

    Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation

    Cohort studyLupus & APS

  28. Arthritis Rheumatol

    T Cell Plasticity in Systemic Lupus Erythematosus Revealed by Large‐Scale T Cell Receptor Repertoire and Transcriptome Studies

    Mechanistic studyLupus & APS

  29. Arthritis Rheumatol

    Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen‐Specific CD4 T Cells in Rheumatoid Arthritis and Health

    Mechanistic studyRA

  30. Arthritis Rheumatol

    Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

    Cohort studySystemic sclerosis

  31. Arthritis Rheumatol

    The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria

    Guideline or statementAcross diseases

  32. Arthritis Rheumatol

    A Pragmatic Trial of a Shared Decision‐Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ ‐ SAFE Study

    Research articleLupus & APS

  33. Arthritis Rheumatol

    Integrative Single‐Cell RNA Sequencing and Spatial Transcriptomics Uncover Distinct Fibroblast–Macrophage Crosstalk in Human Hip Synovium Between Patients With Femoroacetabular Impingement and Osteoarthritis

    Mechanistic studyOsteoarthritis

  34. Arthritis Rheumatol

    Cytokine Profiling of Systemic Sclerosis–Related Pulmonary Hypertension

    Diagnostic or prognostic studySystemic sclerosis

  35. Arthritis Rheumatol

    CD177 + Neutrophils Promote Endothelial Senescence Through Extracellular Traps in Behçet Disease

    Mechanistic studyVasculitis & PMR

  36. Arthritis Rheumatol

    Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

    Randomized controlled trialSpondyloarthritis & PsA

  37. Arthritis Rheumatol

    B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis

    Research articleLupus & APS

  38. Arthritis Rheumatol

    Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

    Diagnostic or prognostic studyRA

  39. Arthritis Rheumatol

    18F ‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis

    Secondary analysisVasculitis & PMR

  40. Arthritis Rheumatol

    Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine

    Cohort studyLupus & APS

All 607 Briefs in ExploreShowing Briefs 41–80 of 607, newest first